Abstract
Background
The COVID-19 pandemic underscores the necessity for proactive measures against emerging diseases, epitomized by WHO's “Disease X.” Among the myriad of indicators tracking COVID-19 progression, the count of hospitalized patients assumes a pivotal role. This metric facilitates timely responses from government agencies, enabling proactive allocation and management of medical resources.
Objective
In this study, we introduce a novel hybrid intelligent approach, the EMD&LSTM-ARIMA model.
Results
Our analysis reveals that all forecasted error rates remain below 10%, with Mean Absolute Percentage Error (MAPE) values obtained for these four countries as 2.30%, 3.33%, 1.63%, and 2.89%, respectively.
Conclusion
Our proposed EMD&LSTM-ARIMA model demonstrates robust forecasting performance, particularly for COVID-19 hospitalization data.
Get full access to this article
View all access options for this article.
